These results indicated that knockdown of PRDX1 inhibited xenograft tumor growth, which was rescued by treatment with Fer-1 and TBHQ, probably due to reduced ferroptosis through activating NRF2-GPX4 signalling pathway (Fig. S5). Here, GPX4 is linked to neoplasm.